Diabetes is a common chronic disease that can lead to related complications such as osteoporosis. Currently, there is a significant amount of research on the pathogenesis of diabetes-related osteoporosis, focusing on aspects such as high blood sugar, oxidative stress response, changes in cytokines and hormones, etc. The pathogenesis of diabetes is complex and diverse. It is of great significance to have a deeper understanding of its pathogenesis, clarify the relationship between diabetes and osteoporosis, and prevent and treat this disease. This article reviews the latest research findings on the pathogenesis of type 2 diabetes-related osteoporosis at home and abroad, aiming to provide reference for subsequent research and clinical practice.

Jiazi Su, Yanru Zhang. Research Progress on the Pathogenesis of Type 2 Diabetes-Related Osteoporosis. International Journal of Frontiers in Medicine (2024), Vol. 6, Issue 4: 21-27. https://doi.org/10.25236/IJFM.2024.060403.

[1] Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017 Jun 27; 317(24):2515-2523.

[2] Demir S, Nawroth PP, Herzig S, et al. Emerging Targets in Type 2 Diabetes and Diabetic Complications. Adv Sci (Weinh). 2021 Sep;8(18):e2100275.

[3] Lorentzon M, Abrahamsen B. Osteoporosis epidemiology using international cohorts. Curr Opin Rheumatol. 2022 Sep 1; 34(5):280-288.

[4] arcía-Hernández A, Arzate H, Gil-Chavarría I, et al. High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone. 2012 Jan; 50(1):276-88.

[5] Chen B, He Q, Yang J, et al. Metformin suppresses Oxidative Stress induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis. Life Sci. 2023 Jan 1; 312: 121092.

[6] Zhang C, Wei W, Chi M, et al. FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions. J Diabetes Res. 2019 Nov 25;2019:6757428.

[7] Park SK, Jung JY, Oh CM, et al. Fasting glucose level and the risk of incident osteoporosis in the Koreans. Bone. 2021 Jan; 142:115690.

[8] Kumari C, Yagoub G, Ashfaque M, et al. Consequences of Diabetes Mellitus in Bone Health: Traditional Review. Cureus. 2021 Mar 11; 13(3):e13820.

[9] Rharass T, Lucas S. High Glucose Level Impairs Human Mature Bone Marrow Adipocyte Function Through Increased ROS Production. Front Endocrinol (Lausanne). 2019 Sep 10; 10:607.

[10] Iantomasi T, Romagnoli C, Palmini G, et al. Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs. Int J Mol Sci. 2023 Feb 14; 24(4): 3772.

[11] Moris D, Spartalis M, Tzatzaki E, et al. The role of reactive oxygen species in myocardial redox signaling and regulation. Ann Transl Med. 2017 Aug;5(16):324.

[12] Zhang C, Li H, Li J, et al. Oxidative stress: A common pathological state in a high-risk population for osteoporosis. Biomed Pharmacother. 2023 Jul;163:114834.

[13] Zhang Q, Wang S, Wang F, et al. TBBPA induces inflammation, apoptosis, and necrosis of skeletal muscle in mice through the ROS/Nrf2/TNF-α signaling pathway. Environ Pollut. 2023 Jan 15; 317: 120745.

[14] Qian H, Jia J, Yang Y, et al. A Follicle-Stimulating Hormone Exacerbates the Progression of Periapical Inflammation Through Modulating the Cytokine Release in Periodontal Tissue. Inflammation. 2020 Aug; 43(4):1572-1585.

[15] Agidigbi TS, Kim C. Reactive Oxygen Species in Osteoclast Differentiation and Possible Pharmaceutical Targets of ROS-Mediated Osteoclast Diseases. Int J Mol Sci. 2019 Jul 22; 20(14):3576.

[16] Wong P, Lv Z, Li J, et al. A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species. Oxid Med Cell Longev. 2022 Nov 4; 2022:5982014.

[17] Wang T, He C. TNF-α and IL-6: The Link between Immune and Bone System. Curr Drug Targets. 2020; 21(3):213-227.

[18] Narimiya T, Kanzaki H, Yamaguchi Y, et al. Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression. Bone Rep. 2019 Nov 1; 11:100228.

[19] Arai M, Shibata Y, Pugdee K, et al. Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life. 2007 Jan;59(1):27-33.

[20] Wu B, Fu Z, Wang X, et al. A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment. Front Endocrinol (Lausanne). 2022 Dec 14; 13:1052592.

[21] Kasukawa Y, Miyakoshi N, Mohan S. The anabolic effects of GH/IGF system on bone. Curr Pharm Des. 2004; 10(21):2577-92.

[22] Zhang Y, Huang X, Sun K, et al. The Potential Role of Serum IGF-1 and Leptin as Biomarkers: Towards Screening for and Diagnosing Postmenopausal Osteoporosis. J Inflamm Res. 2022 Jan 22; 15: 533-543.

[23] Feng J, Meng Z. Insulin growth factor-1 promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells through the Wnt/β-catenin pathway. Exp Ther Med. 2021 Aug; 22(2): 891.

[24] Wang Y, Cheng Z, Elalieh HZ, et al. IGF-1R signaling in chondrocytes modulates growth plate development by interacting with the PTHrP/Ihh pathway. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research. 2011 Jul; 26(7):1437-1446.

[25] Wang X, Jiang L, Shao X. Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM. Ther Clin Risk Manag. 2021 Aug 31; 17: 909-916.

[26] Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol. 2006 Jan;2(1):35-43.

[27] Gong X, Tang Y, Yu SS, et al. Elevated serum leptin may be associated with disease activity and secondary osteoporosis in Chinese patients with rheumatoid arthritis. Clin Rheumatol. 2023 Dec; 42(12): 3333-3340.

[28] Obradovic M, Sudar-Milovanovic E, Soskic S, et al. Leptin and Obesity: Role and Clinical Implication. Front Endocrinol (Lausanne). 2021 May 18;12:585887.

[29] Lin Z, Yu G, Xiong S, et al. Leptin and melatonin's effects on OVX rodents' bone metabolism. Front Endocrinol (Lausanne). 2023 Jun 27;14:1185476.

[30] Muruganandan S, Roman AA, Sinal CJ. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res. 2010 Feb;25(2):222-34.

[31] Li J, Zhang T, Huang C, et al. Chemerin located in bone marrow promotes osteogenic differentiation and bone formation via Akt/Gsk3β/β-catenin axis in mice. J Cell Physiol. 2021 Aug; 236(8): 6042-6054.

[32] Shu L, Fu Y, Sun H. The association between common serum adipokines levels and postmenopausal osteoporosis: A meta-analysis. J Cell Mol Med. 2022 Aug;26(15):4333-4342.

[33] Ebrahimi-Mamaeghani M, Mohammadi S, Arefhosseini SR, et al. Adiponectin as a potential biomarker of vascular disease. Vasc Health Risk Manag. 2015 Jan 16;11:55-70.

[34] Roomi AB, Nori W, Al-Badry SH. The Value of Serum Adiponectin in Osteoporotic Women: Does Weight Have an Effect? J Obes. 2021 Nov 9;2021:5325813.

[35] Karim K, Giribabu N, Salleh N. Marantodes pumilum Var Alata (Kacip Fatimah) ameliorates derangement in RANK/RANKL/OPG pathway and reduces inflammation and oxidative stress in the bone of estrogen-deficient female rats with type-2 diabetes. Phytomedicine. 2021 Oct;91:153677.

[36] Ran C, Xiaojuan X, Wenxue G, et al. Sexual dimorphism in the relation between sex hormones and osteoporosis in patients with type 2 diabetes mellitus. J Bone Miner Metab. 2022 May;40(3):460-467.

[37] LIU M, LV N, XV H, et al. Study on the model of type 2 diabetic nephropathy with osteoporosis in rats [in Chinese].Chinese Journal of Osteoporosis, 2020,26(11):1592-1597.

[38] Almutlaq N, Neyman A, DiMeglio LA. Are diabetes microvascular complications risk factors for fragility fracture? Curr Opin Endocrinol Diabetes Obes. 2021 Aug 1; 28(4):354-359.

[39] Xu X, Zhang M, Fei Z, et al. Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study. Osteoporos Int. 2021 Jun;32(6):1185-1193. 

[40] LI S, SHI J, TIAN X, et al. Blood sugar control status and complications of type 2 diabetes patients of different ages [in Chinese]. Chinese Journal of Gerontology, 2018, 38(16):3854-3857.

[41] CHEN Q, YAN X, HU J, et al. The correlation between diabe te s combined with oste oporosis and diabe tic microvascular complications [in Chinese].Chinese Journal of Osteoporosis, 2017, 23(03): 411-415.

[42] Delsmann MM, Strahl A, Mühlenfeld M, et al. High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty. Osteoporos Int. 2021 Aug; 32(8): 1661-1668.

[43] Özpak Akkuş Ö, Atalay B. Post-menopausal osteoporosis: do body composition, nutritional habits, and physical activity affect bone mineral density? Nutr Hosp. 2020 Oct 21; 37(5):977-983. English.

[44] Lee JH, Kim JH, Hong AR, et al. Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes. Korean J Intern Med. 2020 Nov;35(6):1432-1442.

[45] Klein S, Gastaldelli A, Yki-Järvinen H, et al. Why does obesity cause diabetes? Cell Metab. 2022 Jan 4; 34(1):11-20.

[46] American Diabetes Association. 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S34-S39.

[47] Adami G, Gatti D, Rossini M, et al. Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort. Osteoporos Int. 2020 Nov;31(11):2113-2122.

[48] Li T, Hu L, Yin XL, et al. Prevalence and Risk Factors of Osteoporosis in Patients with Type 2 Diabetes Mellitus in Nanchang (China): A Retrospective Cohort Study. Diabetes Metab Syndr Obes. 2022 Sep 28; 15:3039-3048.

[49] Haeri NS, Perera S, Greenspan SL. The association of vitamin D with bone microarchitecture, muscle strength, and mobility performance in older women in long-term care. Bone. 2023 Nov; 176: 116867.

[50] Wang X, Ma H, Sun J, et al. Mitochondrial Ferritin Deficiency Promotes Osteoblastic Ferroptosis Via Mitophagy in Type 2 Diabetic Osteoporosis. Biol Trace Elem Res. 2022 Jan;200(1):298-307.

[51] Ye YW, Lu K, Yin Y, et al. Association between serum 25-hydroxyvitamin D and fasting blood glucose in osteoporosis patients. Sci Rep. 2023 Nov 1; 13(1):18812.

[52] Bouillon R, Manousaki D, Rosen C, et al. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. 2022 Feb; 18(2):96-110.

[53] Fu W, Fan J. Intervention effect of exercise rehabilitation therapy on patients with type 2 diabetic osteoporosis. Am J Transl Res. 2021 Apr 15; 13(4):3400-3408.

[54] Vallibhakara SA, Nakpalat K, Sophonsritsuk A, et al. Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial. Nutrients. 2021 Nov 25; 13(12):4226.